209 related articles for article (PubMed ID: 30053375)
1. Nitric Oxide Activates β-Cell Glucokinase by Promoting Formation of the "Glucose-Activated" State.
Seckinger KM; Rao VP; Snell NE; Mancini AE; Markwardt ML; Rizzo MA
Biochemistry; 2018 Aug; 57(34):5136-5144. PubMed ID: 30053375
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
Ding SY; Tribble ND; Kraft CA; Markwardt M; Gloyn AL; Rizzo MA
Mol Endocrinol; 2010 Jan; 24(1):171-7. PubMed ID: 19934346
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Glucokinase by Intracellular Calcium Levels in Pancreatic β Cells.
Markwardt ML; Seckinger KM; Rizzo MA
J Biol Chem; 2016 Feb; 291(6):3000-9. PubMed ID: 26698632
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells.
Ding SY; Nkobena A; Kraft CA; Markwardt ML; Rizzo MA
J Biol Chem; 2011 May; 286(19):16768-74. PubMed ID: 21454584
[TBL] [Abstract][Full Text] [Related]
5. Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase.
Larion M; Salinas RK; Bruschweiler-Li L; Miller BG; Brüschweiler R
PLoS Biol; 2012; 10(12):e1001452. PubMed ID: 23271955
[TBL] [Abstract][Full Text] [Related]
6. Role of connecting loop I in catalysis and allosteric regulation of human glucokinase.
Martinez JA; Larion M; Conejo MS; Porter CM; Miller BG
Protein Sci; 2014 Jul; 23(7):915-22. PubMed ID: 24723372
[TBL] [Abstract][Full Text] [Related]
7. Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.
Markwardt ML; Nkobena A; Ding SY; Rizzo MA
Mol Endocrinol; 2012 Sep; 26(9):1617-29. PubMed ID: 22771492
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Origins of Enzyme Activation in Human Glucokinase Variants Associated with Congenital Hyperinsulinism.
Sternisha SM; Liu P; Marshall AG; Miller BG
Biochemistry; 2018 Mar; 57(10):1632-1639. PubMed ID: 29425029
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular regulation of human glucokinase.
Sternisha SM; Miller BG
Arch Biochem Biophys; 2019 Mar; 663():199-213. PubMed ID: 30641049
[TBL] [Abstract][Full Text] [Related]
10. Dual allosteric activation mechanisms in monomeric human glucokinase.
Whittington AC; Larion M; Bowler JM; Ramsey KM; Brüschweiler R; Miller BG
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11553-8. PubMed ID: 26283387
[TBL] [Abstract][Full Text] [Related]
11. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
12. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
13. Chronic ethanol consumption-induced pancreatic {beta}-cell dysfunction and apoptosis through glucokinase nitration and its down-regulation.
Kim JY; Song EH; Lee HJ; Oh YK; Park YS; Park JW; Kim BJ; Kim DJ; Lee I; Song J; Kim WH
J Biol Chem; 2010 Nov; 285(48):37251-62. PubMed ID: 20855893
[TBL] [Abstract][Full Text] [Related]
14. Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetes.
Lu B; Kurmi K; Munoz-Gomez M; Jacobus Ambuludi EJ; Tonne JM; Rakshit K; Hitosugi T; Kudva YC; Matveyenko AV; Ikeda Y
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29915142
[TBL] [Abstract][Full Text] [Related]
15. A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
Rees MG; Davis MI; Shen M; Titus S; Raimondo A; Barrett A; Gloyn AL; Collins FS; Simeonov A
PLoS One; 2014; 9(2):e89335. PubMed ID: 24586696
[TBL] [Abstract][Full Text] [Related]
16. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
17. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
18. Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor.
Murphy R; Tura A; Clark PM; Holst JJ; Mari A; Hattersley AT
Diabetologia; 2009 Jan; 52(1):154-9. PubMed ID: 18974968
[TBL] [Abstract][Full Text] [Related]
19. The two major glucokinase isoforms show conserved functionality in β-cells despite different subcellular distribution.
Lu B; Munoz-Gomez M; Ikeda Y
Biol Chem; 2018 May; 399(6):565-576. PubMed ID: 29573377
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
